Merck (MRK) Revenue (2009 - 2026)

Merck (MRK) has 18 years of Revenue data on file, last reported at $16.3 billion in Q1 2026.

• Revenue for Q1 2026 came in at $16.3 billion, up 4.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $65.8 billion (up 2.89% YoY), and the FY2025 annual result was $65.0 billion, up 1.31% from the prior year.
• Revenue eased to $16.3 billion in Q1 2026 per MRK's latest filing, from $16.4 billion in the prior quarter.
• Over five years, Revenue peaked at $17.3 billion in Q3 2025 and troughed at $13.8 billion in Q4 2022.
• A 5-year average of $15.6 billion and a median of $15.8 billion in 2024 frame the typical range for Revenue.
• The sharpest annual moves came in 2022 and 2023: Revenue jumped 49.63% in 2022, then dropped 8.89% in 2023.
• A 5-year view of Revenue shows it stood at $13.8 billion in 2022, then gained by 5.78% to $14.6 billion in 2023, then climbed by 6.79% to $15.6 billion in 2024, then grew by 4.97% to $16.4 billion in 2025, then declined by 0.7% to $16.3 billion in 2026.
• Business Quant data shows MRK's Revenue at $16.3 billion in Q1 2026, $16.4 billion in Q4 2025, and $17.3 billion in Q3 2025.